IGC PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
IGC PHARMA, INC. (IGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 695.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 695.00K shares, a 56.56% decline year-over-year.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 90.00K shares.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 7.75M shares.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 250.00K shares, a 92.98% decline from fiscal 2024.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.56M shares.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- IGC PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 150.00K shares, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 695.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 695.00K shares 10-Q · filed 2026-08-14 | 785.00K shares derived: sum of 3 quarters · filed 2026-08-14 | 8.54M shares derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 90.00K shares derived: sum of 2 quarters · filed 2026-05-15 | 7.84M shares derived: sum of 3 quarters · filed 2026-05-15 | 9.44M shares derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | 90.00K shares derived: 10-KT 9 month − 10-Q 6 month · filed 2026-03-18 | 7.84M shares derived: sum of 2 quarters · filed 2026-03-18 | 9.44M shares 10-KT · filed 2026-03-18 | 9.69M shares derived: sum of 4 quarters · filed 2026-03-18 | |
| 2025-09-30 | 7.75M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | 9.35M shares 10-Q · filed 2025-11-14 | 9.60M shares derived: sum of 3 quarters · filed 2025-11-14 | 9.60M shares derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | 1.60M shares 10-Q · filed 2025-08-14 | 1.85M shares derived: sum of 2 quarters · filed 2025-08-14 | 1.85M shares derived: sum of 3 quarters · filed 2025-08-14 | 1.85M shares derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | 250.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-27 | 250.00K shares derived: sum of 2 quarters · filed 2025-06-27 | 250.00K shares derived: sum of 3 quarters · filed 2025-06-27 | 250.00K shares 10-K · filed 2025-06-27 | |
| 2024-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-14 | 0.00 shares 10-Q · filed 2025-02-14 | 3.56M shares derived: sum of 4 quarters · filed 2025-02-14 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | 3.56M shares derived: sum of 3 quarters · filed 2024-11-12 | 3.56M shares derived: sum of 4 quarters · filed 2024-11-12 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-07 | 3.56M shares derived: sum of 2 quarters · filed 2024-08-07 | 3.56M shares derived: sum of 3 quarters · filed 2024-08-07 | 3.56M shares derived: sum of 4 quarters · filed 2024-08-07 | |
| 2024-03-31 | 3.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | 3.56M shares derived: sum of 2 quarters · filed 2024-06-24 | 3.56M shares derived: sum of 3 quarters · filed 2024-06-24 | 3.56M shares 10-K · filed 2024-06-24 | |
| 2023-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-14 | 0.00 shares 10-Q · filed 2024-02-14 | 0.00 shares derived: sum of 4 quarters · filed 2024-02-14 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | 0.00 shares derived: sum of 3 quarters · filed 2023-11-09 | 0.00 shares derived: sum of 4 quarters · filed 2023-11-09 | |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 | 0.00 shares derived: sum of 2 quarters · filed 2023-08-10 | 0.00 shares derived: sum of 3 quarters · filed 2023-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2023-08-10 | |
| 2023-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-07 | 0.00 shares derived: sum of 2 quarters · filed 2023-07-07 | 0.00 shares derived: sum of 3 quarters · filed 2023-07-07 | 0.00 shares 10-K · filed 2023-07-07 | |
| 2022-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2023-02-14 | 0.00 shares 10-Q · filed 2023-02-14 | 0.00 shares derived: sum of 4 quarters · filed 2023-02-14 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-01 | 0.00 shares 10-Q · filed 2022-11-01 | 0.00 shares derived: sum of 3 quarters · filed 2022-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2022-11-01 | |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-05 | 0.00 shares derived: sum of 2 quarters · filed 2022-08-05 | 0.00 shares derived: sum of 3 quarters · filed 2022-08-05 | ||
| 2022-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | 0.00 shares derived: sum of 2 quarters · filed 2022-06-23 | 150.00K shares 10-K · filed 2022-06-23 | ||
| 2021-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | 150.00K shares 10-Q · filed 2022-02-10 | |||
| 2021-09-30 | 150.00K shares 10-Q · filed 2021-10-29 | ||||
| 2021-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | 0.00 shares derived: sum of 2 quarters · filed 2021-06-14 | 150.00K shares derived: sum of 3 quarters · filed 2021-06-14 | 150.00K shares 10-K · filed 2021-06-14 | |
| 2020-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | 150.00K shares derived: sum of 2 quarters · filed 2021-02-16 | 150.00K shares 10-Q · filed 2021-02-16 | 150.00K shares derived: sum of 4 quarters · filed 2021-02-16 | |
| 2020-09-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-20 | 150.00K shares 10-Q · filed 2020-11-20 | 150.00K shares derived: sum of 3 quarters · filed 2020-11-20 | 150.00K shares derived: sum of 4 quarters · filed 2020-11-20 | |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-19 | 0.00 shares derived: sum of 2 quarters · filed 2020-08-19 | 0.00 shares derived: sum of 3 quarters · filed 2020-08-19 | 0.00 shares derived: sum of 4 quarters · filed 2020-08-19 | |
| 2020-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-07-13 | 0.00 shares derived: sum of 3 quarters · filed 2020-07-13 | 0.00 shares 10-K · filed 2020-07-13 | |
| 2019-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | 0.00 shares derived: sum of 2 quarters · filed 2020-02-10 | 0.00 shares 10-Q · filed 2020-02-10 | 40.00K shares derived: sum of 4 quarters · filed 2020-02-10 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | 0.00 shares 10-Q · filed 2019-11-06 | 40.00K shares derived: sum of 3 quarters · filed 2020-02-10 | -210.00K shares derived: sum of 4 quarters · filed 2020-02-10 | |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-09 | 40.00K shares derived: sum of 2 quarters · filed 2020-02-10 | -210.00K shares derived: sum of 3 quarters · filed 2020-02-10 | ||
| 2019-03-31 | 40.00K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2020-02-10 | -210.00K shares derived: sum of 2 quarters · filed 2020-02-10 | 110.00K shares 10-Q · filed 2020-02-10 | ||
| 2018-12-31 | -250.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | 70.00K shares 10-Q · filed 2019-02-12 | |||
| 2018-09-30 | 320.00K shares 10-Q · filed 2018-10-16 | ||||
| 2018-03-31 | 490.00K shares 10-K · filed 2019-06-14 | ||||
| 2017-12-31 | 1.46M shares 10-Q · filed 2018-02-20 | 1.70M shares derived: sum of 2 quarters · filed 2018-02-20 | 1.90M shares derived: sum of 3 quarters · filed 2018-02-20 | ||
| 2017-09-30 | 240.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-17 | 440.00K shares 10-Q · filed 2017-11-17 | |||
| 2017-06-30 | 200.00K shares 10-Q · filed 2017-08-18 | ||||
| 2017-03-31 | 160.00K shares 10-K · filed 2018-06-21 | ||||
| 2016-03-31 | 10.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-14 | 130.04K shares 10-K · filed 2017-07-14 | 139.30K shares 10-K · filed 2016-07-14 | ||
| 2015-12-31 | 120.00K shares 10-Q · filed 2016-02-16 | ||||
| 2013-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | 269.35K shares 10-Q · filed 2014-02-14 | |||
| 2013-09-30 | 269.35K shares 10-Q · filed 2013-11-08 | ||||
| 2013-03-31 | 269.35K shares 10-Q · filed 2013-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |